Unexpected Finding from Gene Trial Provides DMD Clues

MedPageToday -- Some participants in the pioneering gene therapy trial for Duchenne muscular dystrophy (DMD) were found to have immune reactivity to the dystrophin protein -- in two cases, even before they received the first dose, researchers said.